AU2000233235A1 - Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase - Google Patents
Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromataseInfo
- Publication number
- AU2000233235A1 AU2000233235A1 AU2000233235A AU3323500A AU2000233235A1 AU 2000233235 A1 AU2000233235 A1 AU 2000233235A1 AU 2000233235 A AU2000233235 A AU 2000233235A AU 3323500 A AU3323500 A AU 3323500A AU 2000233235 A1 AU2000233235 A1 AU 2000233235A1
- Authority
- AU
- Australia
- Prior art keywords
- antagonists
- treatment
- aromatase
- interleukin
- high levels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
The invention described herein relates to the use of human interleukin-6 antagonists, totally incapable of binding to gp 130, as specific inhibitors of the enzyme aromatase, useful for the treatment of hormone-dependent tumours, and particularly tumours of the breast.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IT2000/000072 WO2001066131A1 (en) | 2000-03-06 | 2000-03-06 | Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2000233235A1 true AU2000233235A1 (en) | 2001-09-17 |
Family
ID=11133493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2000233235A Abandoned AU2000233235A1 (en) | 2000-03-06 | 2000-03-06 | Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase |
Country Status (17)
Country | Link |
---|---|
US (1) | US7160860B2 (en) |
EP (1) | EP1261367B1 (en) |
JP (1) | JP2003525906A (en) |
KR (1) | KR100694005B1 (en) |
AT (1) | ATE295735T1 (en) |
AU (1) | AU2000233235A1 (en) |
CA (1) | CA2400711A1 (en) |
CZ (1) | CZ20022760A3 (en) |
DE (1) | DE60020269T2 (en) |
DK (1) | DK1261367T3 (en) |
ES (1) | ES2241583T3 (en) |
HU (1) | HUP0300117A3 (en) |
MX (1) | MXPA02008697A (en) |
PL (1) | PL356846A1 (en) |
PT (1) | PT1261367E (en) |
SK (1) | SK12412002A3 (en) |
WO (1) | WO2001066131A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6793678B2 (en) | 2002-06-27 | 2004-09-21 | Depuy Acromed, Inc. | Prosthetic intervertebral motion disc having dampening |
WO2008070863A2 (en) | 2006-12-07 | 2008-06-12 | Interventional Spine, Inc. | Intervertebral implant |
US8900307B2 (en) | 2007-06-26 | 2014-12-02 | DePuy Synthes Products, LLC | Highly lordosed fusion cage |
WO2009092102A1 (en) | 2008-01-17 | 2009-07-23 | Synthes Usa, Llc | An expandable intervertebral implant and associated method of manufacturing the same |
WO2009124269A1 (en) | 2008-04-05 | 2009-10-08 | Synthes Usa, Llc | Expandable intervertebral implant |
US9526620B2 (en) | 2009-03-30 | 2016-12-27 | DePuy Synthes Products, Inc. | Zero profile spinal fusion cage |
US9393129B2 (en) | 2009-12-10 | 2016-07-19 | DePuy Synthes Products, Inc. | Bellows-like expandable interbody fusion cage |
US9592063B2 (en) | 2010-06-24 | 2017-03-14 | DePuy Synthes Products, Inc. | Universal trial for lateral cages |
US8979860B2 (en) | 2010-06-24 | 2015-03-17 | DePuy Synthes Products. LLC | Enhanced cage insertion device |
WO2012003175A1 (en) | 2010-06-29 | 2012-01-05 | Synthes Usa, Llc | Distractible intervertebral implant |
US9402732B2 (en) | 2010-10-11 | 2016-08-02 | DePuy Synthes Products, Inc. | Expandable interspinous process spacer implant |
US8518087B2 (en) | 2011-03-10 | 2013-08-27 | Interventional Spine, Inc. | Method and apparatus for minimally invasive insertion of intervertebral implants |
US8394129B2 (en) | 2011-03-10 | 2013-03-12 | Interventional Spine, Inc. | Method and apparatus for minimally invasive insertion of intervertebral implants |
US8940052B2 (en) | 2012-07-26 | 2015-01-27 | DePuy Synthes Products, LLC | Expandable implant |
US9522070B2 (en) | 2013-03-07 | 2016-12-20 | Interventional Spine, Inc. | Intervertebral implant |
US11426290B2 (en) | 2015-03-06 | 2022-08-30 | DePuy Synthes Products, Inc. | Expandable intervertebral implant, system, kit and method |
US9913727B2 (en) | 2015-07-02 | 2018-03-13 | Medos International Sarl | Expandable implant |
CN109688981A (en) | 2016-06-28 | 2019-04-26 | Eit 新兴移植技术股份有限公司 | Distensible, adjustable angle intervertebral cage |
EP3474782A2 (en) | 2016-06-28 | 2019-05-01 | Eit Emerging Implant Technologies GmbH | Expandable and angularly adjustable articulating intervertebral cages |
US10537436B2 (en) | 2016-11-01 | 2020-01-21 | DePuy Synthes Products, Inc. | Curved expandable cage |
US10888433B2 (en) | 2016-12-14 | 2021-01-12 | DePuy Synthes Products, Inc. | Intervertebral implant inserter and related methods |
US10398563B2 (en) | 2017-05-08 | 2019-09-03 | Medos International Sarl | Expandable cage |
US11344424B2 (en) | 2017-06-14 | 2022-05-31 | Medos International Sarl | Expandable intervertebral implant and related methods |
US10940016B2 (en) | 2017-07-05 | 2021-03-09 | Medos International Sarl | Expandable intervertebral fusion cage |
US11446156B2 (en) | 2018-10-25 | 2022-09-20 | Medos International Sarl | Expandable intervertebral implant, inserter instrument, and related methods |
US11426286B2 (en) | 2020-03-06 | 2022-08-30 | Eit Emerging Implant Technologies Gmbh | Expandable intervertebral implant |
US11850160B2 (en) | 2021-03-26 | 2023-12-26 | Medos International Sarl | Expandable lordotic intervertebral fusion cage |
US11752009B2 (en) | 2021-04-06 | 2023-09-12 | Medos International Sarl | Expandable intervertebral fusion cage |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1276555B1 (en) * | 1995-04-28 | 1997-11-03 | Angeletti P Ist Richerche Bio | HUMAN INTERLUCHINA-6 ANTAGONISTS COMPLETELY UNABLE TO FORM A BOND WITH GP 130, AND USE THEM FOR THE PREPARATION OF COMPOSITIONS |
IT1285790B1 (en) * | 1996-09-24 | 1998-06-24 | Angeletti P Ist Richerche Bio | ADENOVIRUS RECOMBINANT DEFECTIVES CODING FOR MUTANTS OF HUMAN INTERLEUKINE 6 (HIL-6) WITH ANTAGONIST ACTIVITY OR |
GB9621095D0 (en) * | 1996-10-09 | 1996-11-27 | Imperial College | Novel system |
US7205280B2 (en) * | 1998-03-11 | 2007-04-17 | Cognosci, Inc. | Methods of suppressing microglial activation |
-
2000
- 2000-03-06 HU HU0300117A patent/HUP0300117A3/en unknown
- 2000-03-06 DE DE60020269T patent/DE60020269T2/en not_active Expired - Fee Related
- 2000-03-06 JP JP2001564783A patent/JP2003525906A/en not_active Withdrawn
- 2000-03-06 ES ES00911250T patent/ES2241583T3/en not_active Expired - Lifetime
- 2000-03-06 CA CA002400711A patent/CA2400711A1/en not_active Abandoned
- 2000-03-06 EP EP00911250A patent/EP1261367B1/en not_active Expired - Lifetime
- 2000-03-06 CZ CZ20022760A patent/CZ20022760A3/en unknown
- 2000-03-06 AU AU2000233235A patent/AU2000233235A1/en not_active Abandoned
- 2000-03-06 KR KR1020027011558A patent/KR100694005B1/en not_active IP Right Cessation
- 2000-03-06 PL PL00356846A patent/PL356846A1/en not_active IP Right Cessation
- 2000-03-06 DK DK00911250T patent/DK1261367T3/en active
- 2000-03-06 AT AT00911250T patent/ATE295735T1/en not_active IP Right Cessation
- 2000-03-06 PT PT00911250T patent/PT1261367E/en unknown
- 2000-03-06 WO PCT/IT2000/000072 patent/WO2001066131A1/en active IP Right Grant
- 2000-03-06 MX MXPA02008697A patent/MXPA02008697A/en active IP Right Grant
- 2000-03-06 SK SK1241-2002A patent/SK12412002A3/en unknown
-
2004
- 2004-11-16 US US10/988,628 patent/US7160860B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1261367B1 (en) | 2005-05-18 |
DK1261367T3 (en) | 2005-09-12 |
MXPA02008697A (en) | 2003-04-14 |
PT1261367E (en) | 2005-09-30 |
US20050090443A1 (en) | 2005-04-28 |
DE60020269D1 (en) | 2005-06-23 |
CZ20022760A3 (en) | 2003-03-12 |
SK12412002A3 (en) | 2002-12-03 |
HUP0300117A2 (en) | 2003-04-28 |
KR20020079984A (en) | 2002-10-21 |
CA2400711A1 (en) | 2001-09-13 |
WO2001066131A1 (en) | 2001-09-13 |
HUP0300117A3 (en) | 2005-09-28 |
ES2241583T3 (en) | 2005-11-01 |
JP2003525906A (en) | 2003-09-02 |
DE60020269T2 (en) | 2006-01-19 |
KR100694005B1 (en) | 2007-03-12 |
PL356846A1 (en) | 2004-07-12 |
ATE295735T1 (en) | 2005-06-15 |
EP1261367A1 (en) | 2002-12-04 |
US7160860B2 (en) | 2007-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2000233235A1 (en) | Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase | |
MXPA05010830A (en) | Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2. | |
YU101503A (en) | A novel engineered superantigen for human therapy | |
EP1485381B8 (en) | Azolylaminoazine as inhibitors of protein kinases | |
YU37304A (en) | Specific binding agents of human angiopoietin-2 | |
MY135766A (en) | Quinolinones and naphthyridinones for treating inflammatory diseases | |
WO2004024097A8 (en) | Compositions and methods for the treatment of immune related diseases | |
MY169308A (en) | Treatment of tnf? related disorders | |
AU2003220300A1 (en) | Compositions useful as inhibitors of protein kinases | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
YU9404A (en) | Peptide-based multimeric targeted contrast agents | |
MY140539A (en) | 1-amino 1h-imidazoquinolines | |
GB0111186D0 (en) | Novel compounds | |
MXPA02011288A (en) | Substituted thioacetamides. | |
AU2002358390A1 (en) | Novel compounds | |
HK1040983A1 (en) | Quinones for treatment of diseases. | |
AU2001234273A1 (en) | Thiazolopyrimidines and their use as modulators of chemokine receptor activity | |
TW200508233A (en) | Chk-1 inhibitors | |
WO2003105753A3 (en) | Targeted enzymes and methods of making and using targeted enzymes. | |
WO2002067771A3 (en) | Chemokine receptors and disease | |
GB0326633D0 (en) | Therapeutic agents | |
AU2001233917A1 (en) | Bcmp-7 as marker for diagnosis of breast cancer | |
AU2002251788A1 (en) | Novel compounds and uses thereof | |
RS20060023A (en) | Use of soluble cd164 in inflammatory and/or autoimmune disorders | |
DE60320422D1 (en) | PROCESSES AND FORMULATIONS SUITABLE FOR REDUCING THE CHOLESTERING CONTENT OF EIGELB |